Outsourced Pharma Capacity Update | July 2023

Kevin Yarnall, Sr. Manager, Manufacturing, presented Emergent's manufacturing capabilities and available capacity at its Rockville, Maryland drug product facility during the Outsourced Pharma Capacity Webinar in June. If you missed the live presentation, watch ondemand to learn how Emergent is equipped to support the scale-up and CGMP manufacturing for your next clinical or commercial therapy.

WATCH THE WEBINAR

OPCU Webinar - JUN2023 - Cover Image

 

Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™

GAITHERSBURG, MD. and BURLINGAME, CA. – Jan. 25, 2021Emergent BioSolutions Inc.(NYSE:EBS) (Emergent) andHumanigen, Inc....

READ MORE

SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions

SIOUX FALLS, S.D. and GAITHERSBURG, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a...

READ MORE

Ondemand Webinar: MANUFACTURING NEXT-GEN THERAPIES  - THE VANRX SA25 ASEPTIC FILLING WORKCELL

Our state-of-the-art Vanrx® SA25 Aseptic Filling Workcell can be deployed to support your clinical or commercial drug product...

READ MORE